Document Classification

Section Type: METHODS

Text: From January 2001 to September 2003, 43 patients with advanced or metastatic colorectal carcinoma were randomized into two groups, group A [CPT-11 90 - 25 mg/m (2) continuous infusion for 10 h and folinic acid (FA) 30 mg x m (-2) x d (-1) + 5-FU 425 mg x m (-2) x d (-1) x 2 d continuous infusion for 48 h, every two weeks as a cycle in total of no less than six cycles] and group B (CPT-11 90 - 125 mg/m (2) continuous infusion for 10 h every two weeks as a cycle in total of no less than six cycles and capecitabine 1250 mg x m (-2) x d (-1) by oral divided into two doses, continuously taken without interruption for three months).